VP, Nonclinical
Peel Therapeutics
Aleah is the Vice President of Nonclinical at Peel Therapeutics where she strategically designs, oversees, and analyzes nonclinical studies conducted across Peel’s drug development programs. Prior to Peel, she led product development at a health-tech startup focused on matching cancer patients with relevant clinical trials. Aleah received her Ph.D. in Genomics and Computational Biology from the University of Pennsylvania and her B.S. from Boston College.